DVA · DaVita Inc
Price
Snapshot
50 fields · last close| Market Cap | $11.95B |
| P/E | 14.10 |
| Float | 34.17M |
| Beta | 0.87 |
| Volatility | 21.8% |
| Exchange | NYSE |
| Sector | Health Care |
| Cap tier | Large cap |
| Macro sensitivity | Moderate |
| Clavix score | 76.6 |
| Price | 187.03 |
| Change | −0.15% |
| Prev Close | 187.31 |
| Open | 189.28 |
| Day Low | 186.54 |
| Day High | 189.91 |
| Avg Vol | 0 |
| Avg $ Vol | $93.48M |
| 52W High | 247.49 |
| 52W Low | 101.00 |
| 52W Pos | 58.7% |
| From High | −24.43% |
| From Low | +85.18% |
| Max DD 1Y | −27.86% |
| Spread | 0.10% |
| Liquidity | Normal |
| SMA 20 | +3.94% |
| SMA 50 | +3.63% |
| SMA 200 | +7.88% |
| RSI (14) | 57.7 |
| Vol 30D | 33.3% |
| Vol 90D | 41.9% |
| 1Y Range | 101–247 |
| Daily bars | 536 |
| Perf Week | +4.50% |
| Perf Month | +2.30% |
| Perf Quarter | −19.99% |
| Perf Half Y | +26.64% |
| Perf Year | +48.66% |
| Perf YTD | +63.33% |
| Prev Day | −0.15% |
| Clavix | B |
| Debt / Eq | 77.99 |
| Curr Ratio | 1.29 |
| Int Cover | 3.6× |
| FCF Margin | 9.6% |
| Rev Growth | +6.5% |
| Profit | Profitable |
| Leverage | Very High |
| Sector rank | 25 / 49 |
What DVA does
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States.
The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers.
It also offers outpatient, hospital inpatient, and home-based hemodialysis dialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.
In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services.
Further, it engages in the transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016.
DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.
Clavix risk grade
regraded every trading dayDVA grades B, 76.6 of 100. Steadiest on Sector Resilience (74), most exposed on Price Stability (57, mixed). 3 of the 4 weighted dimensions sit above the Health Care median. Ranks 25 of 49 in Health Care by Clavix score.
How rough the ride is
| DVA | Health Care median | |
|---|---|---|
| Betavs the overall market · lower is steadier | 0.87 | 0.84 |
| Volatilityannualized | 21.8% | 20.9% |
| Max drawdown, past yearworst peak-to-trough fall | −27.9% | — |
| Typical daily movemedian absolute daily change | 1.15% | — |
| Days beyond ±3%of the last 252 sessions | 26 (10%) | — |
How its days are spread
Daily returns over the last 252 sessions in 1% bins. Moves beyond ±6% land in the end bins.
52-week range
The bar runs from the lowest to the highest close of the last 252 sessions; the marker is the latest close.
Drawdown from the 1-year peak
Percent below the running high over the last 12 months. Zero is a fresh high.
Market sensitivity
| DVA | Health Care median | |
|---|---|---|
| Beta to the markethow much it swings with the S&P 500 · lower is safer | 0.87 | 0.84 |
| Macro sensitivityrate, dollar and credit exposure bucket | Moderate | Moderate 53% of 49 |
Where it sits on the macro scale
Low means rates, the dollar and credit spreads barely move it. Very High means they drive a large share of its swings. The counts are how many Health Care names sit in each bucket.
Where it ranks in its sector
Rank by Clavix score within the sector. Right is the top of the sector.
Price performance
| DVA | |
|---|---|
| 1 week | +4.5% |
| 1 month | +2.3% |
| Year to date | +63.3% |
| 1 year | +48.7% |
Context for the rank, not itself a risk measure.
Recent coverage, scored
| DVA | |
|---|---|
| Articles scoredthe most recent scored coverage, up to 30 | 30 since 4 Aug |
| Average score0 most bearish, 100 most bullish | 56 |
| Bullish · bearisharticles above 60 · below 40 | 14 · 7 |
| Directionarticles whose tone is improving vs worsening | 14 ↑ 7 ↓ |
Where the article scores land
Each bar is a 10-point band of article scores. Below 40 reads bearish, above 60 bullish.
Balance sheet, against the sector
The shaded band is the middle half of the 49 Health Care names Clavix covers; the tick is the sector median.
Growth
| DVA | |
|---|---|
| Revenue growthyear over year | +6.5% |
Financial Health is shown but does not count toward the grade. Why
0–100, higher is safer. The tick on each bar is the Health Care median. Click a dimension for the evidence behind it. Financial Health is shown but does not count toward the grade.
Recent news
most recent scored articles · the chip is the article’s score · click to openWall Street Zen upgraded its rating on DaVita from "hold" to "buy" in a research note released Saturday. No price target or specific reasons for the upgrade were disclosed in the article.
DaVita will present seven clinical studies at the American Society of Nephrology Kidney Week 2026, covering middle molecule clearance (removing mid-sized waste molecules from blood during dialysis), home dialysis, and patient experience. The company describes this as one of its largest research showings at the conference in recent years.
An analyst-style note recommends holding DaVita stock, citing growth in its Integrated Kidney Care program, improving treatment economics, and broader formulary adoption as positives, while flagging payer-mix pressures and costs as ongoing concerns.
An article argues DaVita stock should be kept in a portfolio, citing growth in its Integrated Kidney Care (IKC) program, improving treatment economics and stronger formulary adoption, while flagging payer-mix pressures and costs as ongoing concerns. The piece is short on specific developments and reads more like a balanced thesis than a news report.
The article is cut off and does not provide the conclusion of the analysis.
Nearest peers by size
Health Care| Ticker | Company | Grade | Mkt cap | P/E | Beta | |
|---|---|---|---|---|---|---|
| BTSG | Brightspring Health Services Inc | B- | $12.04B | 32.91 | 1.88 | Compare |
| PEN | Penumbra Inc | A+ | $12.64B | 78.70 | 0.69 | Compare |
| COO | Cooper Companies Inc | B- | $11.02B | 19.32 | 0.82 | Compare |
| BAX | Baxter International Inc | B | $13.07B | — | 0.66 | Compare |
| UHS | Universal Health Services Inc | A- | $10.91B | 7.15 | 1.11 | Compare |
| MOH | Molina Healthcare Inc | B | $10.82B | 22.93 | 0.73 | Compare |
| ALGN | Align Technology Inc | B | $10.46B | 25.30 | 1.74 | Compare |
| GMED | Globus Medical Inc | B | $10.30B | 19.24 | 0.97 | Compare |
You just read one holding. Clavix reads the whole portfolio.
Every position you own, graded on the same five dimensions, with an alert when a grade moves. 1 month free on iPhone.